{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T11:10:05Z","timestamp":1770721805997,"version":"3.49.0"},"reference-count":21,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2012,4,30]],"date-time":"2012-04-30T00:00:00Z","timestamp":1335744000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chem Biol Drug Des"],"published-print":{"date-parts":[[2012,8]]},"abstract":"<jats:p>A new class of 1<jats:italic>H<\/jats:italic>\u2010benzimidazolecarboxamidines was synthesized and evaluated for <jats:italic>in vitro<\/jats:italic> antibacterial and antifungal activities, including drug\u2010resistant bacterial strains. The most potent compound (<jats:bold>32<\/jats:bold>) has the same ratio of anti\u2010MRSA activity as Vancomycin (minimal inhibitory concentrations value 0.78\u2003\u03bcg\/mL). The mechanism of action for 1<jats:italic>H<\/jats:italic>\u2010benzimidazolecarboxamidine appears to be different from existing antibacterial agents. These compounds have potential for development as a new class of potent anti\u2010MRSA agent.<\/jats:p>","DOI":"10.1111\/j.1747-0285.2012.01393.x","type":"journal-article","created":{"date-parts":[[2012,4,12]],"date-time":"2012-04-12T20:04:57Z","timestamp":1334261097000},"page":"237-244","source":"Crossref","is-referenced-by-count":15,"title":["Synthesis and Potent <i>In vitro<\/i> Activity of Novel 1<i>H<\/i>\u2010Benzimidazoles as Anti\u2010MRSA Agents"],"prefix":"10.1111","volume":"80","author":[{"given":"Hacer","family":"Karata\u015f","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet","family":"Alp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sulhiye","family":"Y\u0131ld\u0131z","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hakan","family":"G\u00f6ker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,4,30]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1186\/1476-0711-5-2"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.7861\/clinmedicine.4-6-494"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid1104.041167"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)68853-3"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.idc.2004.04.014"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.2174\/1568026033452195"},{"key":"e_1_2_6_8_2","first-page":"469","article-title":"Recent developments in the discovery of novel oxazolidinone antibacterials","volume":"8","author":"Gravestock M.B.","year":"2005","journal-title":"Curr Opin Drug Discov Devel"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2005.01141.x"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkg104"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/ardp.200400884"},{"key":"e_1_2_6_12_2","first-page":"53","article-title":"Synthesis of 1,2\u2010disubstituted benzimidazole\u20105(6)\u2010carboxamides and evaluation of their antimicrobial activity","volume":"51","author":"G\u00f6ker H.","year":"1996","journal-title":"Farmaco"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2005.05.002"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-894X(03)00245-2"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2009.01.075"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2009.06.077"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-894X(01)00024-5"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.42.10.2503"},{"key":"e_1_2_6_19_2","first-page":"o1535","article-title":"Methyl 1\u2010n\u2010butyl\u20102\u2010(3,4\u2010dichlorophenyl)\u20101H\u2010benzimidazole\u20105\u2010carboxylate","volume":"60","author":"Arslan B.","year":"2004","journal-title":"Acta Cryst"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0040-4039(02)01754-9"},{"key":"e_1_2_6_21_2","volume-title":"Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically","author":"National Committee for Clinical Laboratory Standards","year":"2000"},{"key":"e_1_2_6_22_2","volume-title":"Manual of Clinical Microbiology","author":"Shadomy S.","year":"1991"}],"container-title":["Chemical Biology &amp; Drug Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1747-0285.2012.01393.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1747-0285.2012.01393.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,7]],"date-time":"2023-10-07T12:58:59Z","timestamp":1696683539000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1747-0285.2012.01393.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,30]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["10.1111\/j.1747-0285.2012.01393.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1747-0285.2012.01393.x","archive":["Portico"],"relation":{},"ISSN":["1747-0277","1747-0285"],"issn-type":[{"value":"1747-0277","type":"print"},{"value":"1747-0285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,30]]}}}